PPT-Patent assertion entities and competition law

Professor Damien Geradin Tilburg University UCL London EDGE Legal University of Melbourne 10 March 2016 What are patent assertion entities Patent assertion entities PAEs are firms acquiring patent portfolios which they monetize through licensing agreements with manufacturers. NextOp Proprietary and Confidential Assertion Based Verification adopted by leading design companies Most effective approach to reduce chip failure Corner case bugs Identify testing coverage holes Reduce overall verification effort Not enough assert Michael Loch, Head of IP, GSMA. 800 . mobile operators . members and . over . 250 associated member companies from . the broader mobile ecosystem, in more than 220 . countries representing 7.4 Billion mobile connections and 3.6 Billion individual subscribers. E. Richard Gold. James McGill Professor, McGill Faculty of Law. Secondary Use Pharmaceutical Patents: Litigation and Trade Policy Briefing. June 5, 2014. Context. Second use inventions – as all others – must be useful. VALUES . DECLINING. ?. GREY . GOLD . ADVISORS, LLC Wild Dunes 2015. Is the US ANTI PATENT?. Hard to Stop . Infringers. Damages Decline. Patent Litigation is Expensive. Patent Win Rates are Low. PTO Invalidates Contested Patents. Steven Steger. September 4, 2014. Reasons for Change. Combatting Patent Licensing Companies. NPEs, PAEs, Patent Trolls. Abusive Litigation Tactics. Supreme Court Scrutiny/Tension with Federal Circuit. Part I: Conduct Cases and Enforcement. 1. 2011 – 2012 Antitrust Update. Conduct Cases. Section 1 of the Sherman Act prohibits agreements and conspiracies that restrain trade. 15 U.S.C. § 1.. Section 2 of the Sherman Act prohibits monopolization.  15 U.S.C. § 2. Modulo di: . INTELLECTUAL PROPERTY. VALUE MANAGEMENT. (Frosinone . ott-dic. 2014, 8 hours – . 1 . CFU). IPV-M (FR) @ 2014. 2014 November, Tuesday 4th . 1. 1. PEng. . . PhD. . Francesco . Rogo. PATENT EXPLOITATION - EXERCISE TEMPLATE. Christian D. . Ehret. John W. . McIlvaine. Craig M. Waller. Table of Contents. The Good: Software/IP . Assets. a.    . Innovation . Identification. b.    . Vetting New Innovations. c.     . fact or opinion. Commonplace assertion. A common unfounded belief. . Playing with frogs gives you warts.. Boys are stronger than girls.. All . Pittbulls. are dangerous.. opinion . A personal belief, feeling, or judgment. . Team. . UNC. 1/29/2016. Agenda. Executive Summary. Choosing 7 year . p. atent over 10 year data protection has great benefits but need to overcome risks. Composition patent. 5 year data protection. Patent power: Prevent sales loss by protecting large US market. Team. . UNC. 1/29/2016. Agenda. Executive Summary. Choosing 7 year . p. atent over 10 year data protection has great benefits but need to overcome risks. Composition patent. 5 year data protection. Patent power: Prevent sales loss by protecting large US market. Access to Innovation: Making Generic Versions . of. . Newer ARVs Affordable. 24 July . 2014. Melbourne, Australia. Mandeep Dhaliwal, Tenu Avafia & Catherine Kirk. HIV, Health and Development Group, UNDP. An Indian Perspective. Ujjwal Kumar, Policy Analyst, CUTS International. SPILF, 19 May 2017. Outline. Policy environment for Ag-biotech seeds (2 slides). Recent merger notifications and CUTS' submissions (3 slides). TRADING AWAY HEALTH: THE TRANS-PACIFIC PARTNERSHIP AGREEMENT (TPP) MSF Access Campaign Médecins Sans Frontières, Rue de Lausanne 78, CP 116, CH-1211 Geneva 21, Switzerland Tel: + 41 (0) 22 849 84